-
M649719-2mgMardepodect hydrochloride (PF-2545920 hydrochloride) is a potent, orally active and selective PDE10A inhibitor with an IC 50 of 0.37 nM, with >:1000-fold selectivity over other PDEs . Mardepodect hydrochloride can cross the blood-brain barrierIn
-
M649719-50mgMardepodect hydrochloride (PF-2545920 hydrochloride) is a potent, orally active and selective PDE10A inhibitor with an IC 50 of 0.37 nM, with >:1000-fold selectivity over other PDEs . Mardepodect hydrochloride can cross the blood-brain barrierIn
-
M649719-5mgMardepodect hydrochloride (PF-2545920 hydrochloride) is a potent, orally active and selective PDE10A inhibitor with an IC 50 of 0.37 nM, with >:1000-fold selectivity over other PDEs . Mardepodect hydrochloride can cross the blood-brain barrierIn
-
M655967-1mlMardepodect hydrochloride (PF-2545920 hydrochloride) is a potent, orally active and selective PDE10A inhibitor with an IC 50 of 0.37 nM, with >:1000-fold selectivity over other PDEs . Mardepodect hydrochloride can cross the blood-brain barrierIn
-
M647501-1mgMarinobufogenin is a strong inhibitor of Na + /K + ATPase that has been identified in mammalian plasmaForm:SolidIC50&: Target:IC50: Na + /K + ATPase.
-
M647501-5mgMarinobufogenin is a strong inhibitor of Na + /K + ATPase that has been identified in mammalian plasmaForm:SolidIC50&: Target:IC50: Na + /K + ATPase.
-
M649512-10mgMARK4 inhibitor 1 is a potent microtubule affinity-regulating kinase 4 (MARK4) inhibitor, with an IC 50 of 1.54 μM. MARK4 inhibitor 1 inhibits cancer cell proliferation, metastasis and induces apoptosisForm:SolidIC50&: Target:IC50: 1.54 μM
-
M649512-1mgMARK4 inhibitor 1 is a potent microtubule affinity-regulating kinase 4 (MARK4) inhibitor, with an IC 50 of 1.54 μM. MARK4 inhibitor 1 inhibits cancer cell proliferation, metastasis and induces apoptosisForm:SolidIC50&: Target:IC50: 1.54 μM
-
M649512-25mgMARK4 inhibitor 1 is a potent microtubule affinity-regulating kinase 4 (MARK4) inhibitor, with an IC 50 of 1.54 μM. MARK4 inhibitor 1 inhibits cancer cell proliferation, metastasis and induces apoptosisForm:SolidIC50&: Target:IC50: 1.54 μM
-
M649512-50mgMARK4 inhibitor 1 is a potent microtubule affinity-regulating kinase 4 (MARK4) inhibitor, with an IC 50 of 1.54 μM. MARK4 inhibitor 1 inhibits cancer cell proliferation, metastasis and induces apoptosisForm:SolidIC50&: Target:IC50: 1.54 μM
-
M649512-5mgMARK4 inhibitor 1 is a potent microtubule affinity-regulating kinase 4 (MARK4) inhibitor, with an IC 50 of 1.54 μM. MARK4 inhibitor 1 inhibits cancer cell proliferation, metastasis and induces apoptosisForm:SolidIC50&: Target:IC50: 1.54 μM
-
M655889-1mlMARK4 inhibitor 1 is a potent microtubule affinity-regulating kinase 4 (MARK4) inhibitor, with an IC 50 of 1.54 μM. MARK4 inhibitor 1 inhibits cancer cell proliferation, metastasis and induces apoptosisIC50&: Target:IC50: 1.54 μM (MARK4).